Statement Of Cash Flows [Abstract]

Medicover - Filing #5861825

Concept 2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Profit (loss)
EUR
EUR
167,000,000 EUR
EUR
EUR
EUR
167,000,000 EUR
21,000,000 EUR
146,000,000 EUR
EUR
EUR
184,000,000 EUR
EUR
176,000,000 EUR
EUR
8,000,000 EUR
176,000,000 EUR
EUR
EUR
EUR
EUR
EUR
Adjustments to reconcile profit (loss) [abstract]
Adjustments for decrease (increase) in inventories
82,000,000 EUR
51,000,000 EUR
Adjustments for unrealised foreign exchange losses (gains)
17,000,000 EUR
65,000,000 EUR
Adjustments for share-based payments
122,000,000 EUR
94,000,000 EUR
Other adjustments for non-cash items
1,000,000 EUR
77,000,000 EUR
Income taxes paid (refund), classified as operating activities
192,000,000 EUR
288,000,000 EUR
Cash flows from (used in) operating activities
2,619,000,000 EUR
2,050,000,000 EUR
Cash flows from (used in) investing activities [abstract]
Cash flows from losing control of subsidiaries or other businesses, classified as investing activities
1,000,000 EUR
140,000,000 EUR
Cash flows used in obtaining control of subsidiaries or other businesses, classified as investing activities
181,000,000 EUR
196,000,000 EUR
Cash advances and loans made to other parties, classified as investing activities
2,000,000 EUR
76,000,000 EUR
Cash receipts from repayment of advances and loans made to other parties, classified as investing activities
3,000,000 EUR
1,000,000 EUR
Interest received, classified as investing activities
53,000,000 EUR
39,000,000 EUR
Other inflows (outflows) of cash, classified as investing activities
233,000,000 EUR
194,000,000 EUR
Cash flows from (used in) investing activities
1,347,000,000 EUR
1,198,000,000 EUR
Cash flows from (used in) financing activities [abstract]
Payments from changes in ownership interests in subsidiaries that do not result in loss of control
834,000,000 EUR
46,000,000 EUR
Proceeds from issuing shares
EUR
3,000,000 EUR
Payments to acquire or redeem entity's shares
EUR
3,000,000 EUR
Proceeds from borrowings, classified as financing activities
8,848,000,000 EUR
4,619,000,000 EUR
Repayments of borrowings, classified as financing activities
7,550,000,000 EUR
3,973,000,000 EUR
Payments of lease liabilities, classified as financing activities
742,000,000 EUR
655,000,000 EUR
Interest paid, classified as financing activities
594,000,000 EUR
465,000,000 EUR
Cash flows from (used in) financing activities
1,080,000,000 EUR
737,000,000 EUR
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes
192,000,000 EUR
115,000,000 EUR
Effect of exchange rate changes on cash and cash equivalents [abstract]
Effect of exchange rate changes on cash and cash equivalents
2,000,000 EUR
11,000,000 EUR
Increase (decrease) in cash and cash equivalents after effect of exchange rate changes
192,000,000 EUR
115,000,000 EUR
Cash and cash equivalents
698,000,000 EUR
508,000,000 EUR
404,000,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.